News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
256 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21246)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
3 (206)
4 (216)
5 (185)
6 (236)
7 (230)
10 (256)
11 (243)
12 (223)
13 (204)
14 (179)
15 (3)
16 (19)
17 (202)
18 (164)
19 (147)
20 (155)
21 (130)
22 (1)
24 (149)
25 (152)
26 (100)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
15
16
17
18
19
20
21
22
24
25
26
Business
American Oriental Bioengineering, Inc. Reports Third Quarter 2008 Financial Results -- Revenue Increased 62% to $70.6 Million in 3Q08 -- -- 3Q08 Net Income Increased 38% to $16.5 Million -- -- 3Q08 Diluted EPS $0.21 versus 3Q07 Diluted EPS $0.16 --
November 10, 2008
·
5 min read
Drug Development
Sepracor, Inc. Release: Results of Studies of ALVESCO(R) for the Treatment of Asthma and OMNARIS(TM) in an HFA Nasal Aerosol Presented at American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting
November 10, 2008
·
1 min read
Drug Development
Geron Corporation Scientists and Collaborators Demonstrate TAT2 - A Small Molecule Telomerase Activator - Enhances Antiviral Function of Immune Cells From HIV+ Donors
November 10, 2008
·
1 min read
Yongye Biotechnology International to Present at Roth Capital ‘China Comes to Vegas’ Conference
November 10, 2008
·
2 min read
Genetown
Idenix Pharmaceuticals, Inc. to Present at Deutsche Bank’s 2008 Biotech Boston Confab
November 10, 2008
·
1 min read
Business
Heska Corporation Names President and COO Michael J. McGinley Selected to Lead Day-to-Day Operations
November 10, 2008
·
3 min read
Drug Development
Resverlogix Corporation Release: RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer’s Disease
November 10, 2008
·
6 min read
Biotech Bay
Dyax Corp. Release: First-Ever Study Conducted Demonstrating Economic, Individual, and Societal Burden of Hereditary Angioedema
November 10, 2008
·
1 min read
Business
GeoVax Labs Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
November 10, 2008
·
5 min read
Business
Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group Comprehensive Investor Relations and Media Outreach to Commence
November 10, 2008
·
3 min read
Previous
7 of 26
Next
